Melissa Vincent
Biographic Data
| ID | 7862587 |
|---|---|
| NAME | Melissa Vincent |
| GIVEN NAMES | Melissa |
| FAMILY NAME | Vincent |
| SIGNATURE | VINCENT M |
| AFFILIATIONS | Stantec (United States) |
| ORCID | 0000-0002-0018-9662 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Evaluation of the Safety and Efficacy of Hand Sanitizer Products Marketed to Children Available during the Covid-19 Pandemic
Hand sanitizer use in the United States (U.S.) increased after the SARS-CoV-2 outbreak. The U.S. Food and Drug Administration (FDA) released temporary manufacturer guidance, changing impurity level limits for alcohol-based hand sanitizers (ABHSs). Since the guidance took effect, the FDA has recommended against using these hand sanitizers due to concerns over safety, efficacy, and/or risk of incidental ingestion. To address current gaps in exposur…
The Long Goodbye
For the past several decades, a relative potency approach has been used to estimate the human health risks from exposure to polycyclic aromatic hydrocarbon (PAH) mixtures. Risk estimates are derived using potency equivalence factors (PEFs; also called relative potency factors [RPFs]), based on the ratio of selected PAHs to benzo[a]pyrene (BaP), expressed qualitatively by orders of magnitude. To quantify PEFs for 18 selected carcinogenic PAHs, a s…
No prominent works on this page.
Evaluation of the Safety and Efficacy of Hand Sanitizer Products Marketed to Children Available during the Covid-19 Pandemic
Hand sanitizer use in the United States (U.S.) increased after the SARS-CoV-2 outbreak. The U.S. Food and Drug Administration (FDA) released temporary manufacturer guidance, changing impurity level limits for alcohol-based hand sanitizers (ABHSs). Since the guidance took effect, the FDA has recommended against using these hand sanitizers due to concerns over safety, efficacy, and/or risk of incidental ingestion. To address current gaps in exposur…
The Long Goodbye
For the past several decades, a relative potency approach has been used to estimate the human health risks from exposure to polycyclic aromatic hydrocarbon (PAH) mixtures. Risk estimates are derived using potency equivalence factors (PEFs; also called relative potency factors [RPFs]), based on the ratio of selected PAHs to benzo[a]pyrene (BaP), expressed qualitatively by orders of magnitude. To quantify PEFs for 18 selected carcinogenic PAHs, a s…
Chemistry (2 works) · Acetaldehyde (1 work) · Bioavailability (1 work) · Bioinformatics (1 work) · Biology (1 work) · Burn Injury Management and Outcomes (1 work) · Carcinogens and Genotoxicity Assessment (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Dermatological diseases and infestations (1 work) · Effects and risks of endocrine disrupting chemicals (1 work)